Intervention

Insulin Pump

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common conditions3
Lead sponsors shown4
Advertisement

Clinical trials

5 shown
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 DiabetesNCT02660827 · 2016-04-18
COMPLETED
Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump TherapyNCT03112538 · 2016-01-01
UNKNOWN
Hybrid Closed Loop Pivotal Trial in Type 1 DiabetesNCT02463097 · 2015-06-01
COMPLETED
Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.NCT01883024 · 2013-06-01
COMPLETED
Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.NCT00287456 · 2006-02-02
WITHDRAWN

Trial status mix

COMPLETED3
UNKNOWN1
WITHDRAWN1

Phase mix

NA4
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.